Yes, the 22-year-old male stem cell donor candidate can and should receive the hepatitis B vaccine.
The donor should be vaccinated with hepatitis B vaccine prior to stem cell donation, as this is both safe and potentially beneficial for the recipient. 1
Rationale for Vaccination
Universal Recommendation Applies
The 2022 ACIP guidelines recommend hepatitis B vaccination for all adults aged 19-59 years, which includes this 22-year-old donor candidate. 1 There are no contraindications to vaccinating healthy stem cell donors, and vaccination poses no risk to the donation process.
Potential Benefit to the Recipient
Research demonstrates that pretransplant vaccination of both donors and recipients produces significantly higher antibody titers in transplant recipients compared to recipient vaccination alone. 2 Multiple studies show that:
- 88% of HBV-vaccinated recipients with vaccinated donors seroconverted to anti-HBs positivity 3
- 83% of HBV-naïve recipients who received stem cells from HBV-immune donors seroconverted after transplantation 3
- Adoptive transfer of immunity against HBV through stem cell transplantation from immunized donors is well-documented 4, 3
This adoptive immunity transfer is particularly important because the AML patient will be severely immunocompromised post-transplant and unable to mount adequate vaccine responses themselves.
Vaccination Timing and Schedule
Standard Adult Dosing
The donor should receive 20 mcg of hepatitis B vaccine at 0,1, and 6 months for optimal immunogenicity. 5 This schedule produces:
- 79% seroprotection at month 6
- 96% seroprotection at month 7
- GMT of 2,204 mIU/mL among seroconverters 5
Alternative Accelerated Schedule
If donation timing is urgent, an accelerated schedule at 0,1, and 2 months can be used, which produces:
- 99% seroprotection by month 3
- Sustained protection through month 12 5
A booster dose at month 12 significantly increases GMT to 9,163 mIU/mL 5, which could be considered post-donation if the donor remains willing.
Important Caveats
Check Prior Immunity First
Before vaccinating, obtain hepatitis B serologies (HBsAg, anti-HBs, anti-HBc) to document baseline status. 5 If the donor already has protective anti-HBs titers (≥10 mIU/mL), additional vaccination is unnecessary though not harmful. 1
No Delay in Donation Required
Vaccination does not require postponement of stem cell donation. The donor can proceed with collection even if the vaccine series is incomplete, though ideally at least 2 doses should be given before donation if time permits.
Risk of De Novo HBV Infection in Recipients
Studies show that 31% of HBV-naïve recipients with HBV-naïve donors acquired de novo HBV infection post-transplant. 3 This underscores the importance of donor vaccination as a protective strategy for the recipient.
Bottom line: Vaccinate the donor now with the standard or accelerated hepatitis B vaccine series. This is safe, recommended by guidelines, and provides potential adoptive immunity benefit to the AML patient who will be unable to mount adequate vaccine responses during their immunocompromised state post-transplant.